|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Identifying patients at high risk for stroke despite anticoagulation:a comparison of con-temporary stroke risk stratification schemes in an anticoagu-lated atrial fibrillation cohort显示文摘 | Lip GY Frison L Halperin JL | | 0，，： | 1 |
| 2 | Support vector machine for multifrequency SAR polarimetric data classification 显示文摘 | LARDEUX C FRISON P L TISON C | 2009 | IEEE Transactions on Geoscience and Remote Sensing2009，47，12： | 1 |
| 3 | Ximelagatran vs warfarin for stroke prevention in patients with nonvalvular atrial fibrillation: a randomized trial 显示文摘 | Albers GW Diener HC Frison L | 2005 | JAMA2005，293，6： | 1 |
| 4 | Therapeutic gamma-hydroxybutyric acid monitoring in plasma and urine by gas chromatography-mass spectrometry 显示文摘 | Ferrara SD Tedeschi L Frison G | 1993 | J PharmBiomed Anal1993，11，： | 1 |
| 5 | Reproducibili- ty of three-dimensional cephalometric landmarks in cone- beam and low-dose computed tomography显示文摘 | Olszewski R Frison L Wisniewski M | 2013 | Clin Oral ln- vestig2013，17，1： | 1 |
| 6 | Ximelagatran vs warfarin for stroke prevention in patients with nonvalvular atrial fibrillation : a randomized tri- M显示文摘 | Albers GW Diener HC Frison L | 2005 | JAMA2005，293，6： | 1 |
| 7 | Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated pa- tients with atrial fibrillation:the HAS-BLED (Hypertension,Ab- normal Renal/Liver Function,Stroke,Bleeding History or Predis- position,Labile INR,Elderly,Drugs/Alcohol Concomitantly) score显示文摘 | Lip GY Frison L HaIperin JL | 2011 | J Am Coll Cardiol2011，57，2： | 1 |
| 8 | Ximelagatran vs warfarin for stroke prevention in patients with nonvalvular atrial fibrillation:a randomized trial显示文摘 | Diener HC Frison L | 2005 | JAMA2005，293，6： | 1 |
| 9 | Classification Vegetation Using Muhifrequeney Partial SAR 显示文摘 | LARDEUX of Tropical Polarimetry Letters 201 C FRISON P L TISON C | | IEEE Geoscience and Remote Sensing I0，8，1： | 1 |
| 10 | Effect of hypertension on anticoagula: ted patients with atrial fibrillation 显示文摘 | Lip GY Frison L Grind M | 2007 | Eur Heart J2007，28，9： | 1 |
| 11 | Ximelagatran, an oral direct thrombin inhibitor, has a low potential for cytochrome P450-mediated drug-drug interactions显示文摘 | Bredberg E Andersson TB Frison L | 2003 | Clin Pharmacokinet2003，42，8： | 1 |
| 12 | Comparativevalidation of a novel risk score for predicting bleeding risk inanticoagulated patients with atrial fibrillation : the HAS-BLED(Hypertension, Abnormal Renal/Liver Function, Stroke,Bleeding History or Predisposition, Labile INR,Elderly,Drugs/Alcohol Concomitantly) score 显示文摘 | LIP G Y FRISON L HALPERIN J L | 2011 | J Am Coll Cardiol2011，57，2： | 1 |
| 13 | Effect of hypertension on anti- coagulated patients with atrial fibrillation显示文摘 | Lip GY Frison L Grind M etal | 2007 | Eur Heart J2007，28，6： | 1 |
| 14 | Ximelagatran vs warfarin for stroke prevention in patients with nonvalvular atrial fibrillation: a ran- domized trial 显示文摘 | Albers GW Diener HC Frison L | 2005 | JAMA2005，293，6： | 1 |
| 15 | A dose-ranging study of the oral direct thrombin inhibitor,ximelagatran,and its subcutaneous form,melagatran,compared with dalteparin in the prophylaxis of thromboembolism after hip or knee replacement:Melagatran for Thrombin inhibition in Orthopaedic surgery显示文摘 | Eriksson BL Arfwidsson AC Frison L | 2002 | Thromb Haemost2002，13，87： | 1 |
| 16 | Influence of age on the pharmacokinetics and pharmacodynamics of ximelagatran, an oral direct thrombin inhibitor 显示文摘 | Johansson LC Frison L Logren U | 2003 | Clin Pharmacokinet2003，42，4： | 1 |
| 17 | Analysis of proteins from membrane-enriched cerebellar preparations by two-dimensional electrophoresis and mass spectrometry显示文摘 | Frison G Wikstrom L | 1999 | Electrophoresis1999，20，： | 1 |
| 18 | Ximelagatran vs warfarin for stroke prevention in patients with nonvalvular atrial fibrilla- tion; a randomized trial显示文摘 | Albers GW Diener HC Frison L | 2005 | JAMA2005，293，6： | 1 |
| 19 | Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation: the HAS-BLED (Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly, Drugs/Alcohol Concomitantly) score显示文摘 | Lip GY Frison L Halperin JL | 2011 | J Am CoU Cardiol2011，57，2： | 1 |
| 20 | Ximelagatran vs warfarin for stroke prevention with nonvalvular atrial fibrilla- tion: a randomized trial显示文摘 | Albers GW Diener HC Frison L | 2005 | JAMA2005，293，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员